Some of the most compelling research in peptide science centers on a simple question: what if you could activate tissue repair, reduce inflammation, and support skin regeneration simultaneously? Glow is Combat Research’s answer to that question — a triple-peptide blend combining BPC-157 (10mg), TB-500 (10mg), and GHK-Cu (20mg) in a single vial. Each compound has its own distinct body of peer-reviewed research; together, they target overlapping biological pathways in a way that’s drawn serious interest from researchers studying recovery, longevity, and skin biology.
What Is Glow?
Glow is a pre-formulated research peptide blend containing three compounds with complementary mechanisms. Rather than sourcing and managing three separate vials, the blend provides all three in calibrated doses optimized for combined protocols. Each component targets related but distinct physiological processes:
BPC-157 is a 15-amino acid synthetic peptide derived from a protein found in human gastric juice. It is one of the most extensively studied healing peptides, with research spanning tendon and ligament repair, gastrointestinal healing, neuroprotection, and angiogenesis.
TB-500 (Thymosin Beta-4) is a naturally occurring peptide found throughout the body, most abundantly in platelets and wound fluid. It promotes actin polymerization, cell migration, and angiogenesis — all critical components of the tissue repair cascade.
GHK-Cu (Glycine-Histidine-Lysine-Copper) is a naturally occurring copper peptide complex found in human blood plasma, saliva, and urine. Its serum levels decline dramatically with age, and it is among the most studied compounds in skin biology and wound healing research.
Research Overview
BPC-157 — Healing and Systemic Repair: Published research has demonstrated BPC-157’s ability to accelerate tendon-to-bone healing, protect against NSAID-induced gut damage, and promote angiogenesis in injured tissue. A key mechanism involves upregulation of the VEGF pathway and modulation of the nitric oxide system. PubMed: 33430971 | PubMed: 30609466
TB-500 — Tissue Regeneration and Inflammation: Thymosin Beta-4 has been studied for its role in cardiac repair, wound healing, and reduction of fibrosis. Research published in the Annals of the New York Academy of Sciences demonstrated TB-500’s promotion of endothelial cell and keratinocyte migration, making it particularly relevant for skin and connective tissue protocols. PubMed: 25686104
GHK-Cu — Skin Regeneration and Anti-Aging: Dr. Loren Pickart’s pioneering research established GHK-Cu as a potent activator of collagen, elastin, and glycosaminoglycan synthesis. More recent studies have explored GHK-Cu’s ability to upregulate over 4,000 genes associated with tissue repair and to suppress genes associated with inflammation and cancer progression. PubMed: 25874786
For a broader literature search across all three compounds: Google Scholar — BPC-157 TB-500 GHK-Cu Research
Community Discussion
The peptide research community has extensively discussed combination protocols involving BPC-157, TB-500, and GHK-Cu. Discussions range from injury recovery stacking strategies to skin health and systemic anti-aging applications. Top threads can be found on r/Peptides: Reddit r/Peptides — BPC-157 + TB-500 + GHK-Cu
Potential Benefits Studied
Based on published preclinical and early translational research across all three components, the Glow blend has been investigated for:
- Accelerated tendon, ligament, and muscle repair — BPC-157 and TB-500 both target connective tissue healing through complementary angiogenic and cell-migration mechanisms
- Skin collagen and elastin synthesis — GHK-Cu is one of the most documented peptides for dermal collagen production and skin thickness restoration
- Wound healing and tissue regeneration — all three compounds independently support wound closure; in combination they target multiple stages of the healing cascade simultaneously
- Gastrointestinal protection and repair — BPC-157 shows particularly strong evidence for gut lining integrity and NSAID-induced damage protection
- Anti-inflammatory effects — TB-500 and BPC-157 both down-regulate key pro-inflammatory cytokines
- Hair follicle stimulation — GHK-Cu has demonstrated the ability to enlarge hair follicles and stimulate hair growth in research models
- Anti-fibrotic activity — TB-500 has been studied for reducing scar tissue and fibrosis formation post-injury
- Neurological protection — BPC-157 shows neuroprotective effects and potential for supporting dopaminergic system health
Dosage & Administration
Glow is a lyophilized peptide blend administered via subcutaneous injection following reconstitution with bacteriostatic water. Because the vial contains three compounds in specific ratios (BPC-157 10mg, TB-500 10mg, GHK-Cu 20mg), each injection draws from all three simultaneously.
Reconstitution: Add 2–4 mL of bacteriostatic water to yield concentrations suitable for typical research dosing volumes. A 2 mL reconstitution yields 5 mg/mL BPC-157, 5 mg/mL TB-500, and 10 mg/mL GHK-Cu per mL drawn.
Community research protocols for the individual components typically use 250–500 mcg BPC-157 per injection and 2–2.5 mg TB-500 twice weekly, with GHK-Cu at 1–2 mg per session. The Glow formulation is designed so a single dose draws all three compounds in harmonized ratios. Injection site: subcutaneous, typically abdomen. Store unreconstituted at -20°C; refrigerate reconstituted solution and use within 28 days.
Where to Find Glow
Glow (BPC-157 10mg / TB-500 10mg / GHK-Cu 20mg) is available for research at Combat Research: Glow — combatresearch.is
Conclusion
What makes Glow compelling isn’t just the quality of each individual compound — it’s the strategic logic of the combination. BPC-157, TB-500, and GHK-Cu each target wound healing and tissue regeneration through distinct but synergistic pathways: angiogenesis, cell migration, extracellular matrix remodeling, and collagen synthesis. For researchers studying recovery science, skin biology, or systemic repair, having all three in a single pre-formulated vial offers both convenience and protocol precision. In 2026, the evidence base for each component continues to grow, and the Glow blend represents a practical entry point into multi-peptide healing protocols.
Disclaimer: This article is for educational and research purposes only. BPC-157, TB-500, and GHK-Cu are not approved by the FDA for human use. This content does not constitute medical advice. Always consult a licensed healthcare professional before beginning any research protocol.
